Metamaterial Technologies (MTI) acquires MediWiSe; no products released to date

July 29, 2019
Accelerating Materials Innovation More...
11996 thumb square
by Cecilia Gee
Average importance

During our conversation in 2017, MTI said it was in the process of developing an MRI-related device and acquiring an undisclosed health company. Since acquiring MediWiSe in 2018, MTI changed tracks, and it is now working on a noninvasive glucose monitor, yet to be released. While metamaterials as a technology can be made sensitive to specific frequencies, there is a long development road ahead. Moreover, the medical market is difficult to penetrate, and this move will not reap short-term reward for a company arguably overfunded and constrained by investor demand. Clients can expect development of additional medical applications from the company, but be aware it competes with other noninvasive technologies on the market.

For the original news article, click here .

Further Reading


Company Profile | July 30, 2019

Prognoix is developing a wearable device, called the Tumeter, that monitors and provides differential analysis for erectile dysfunction (ED) Tumeter's core technology is its novel sensing technology that passively measure three clinically established data points of an erection – the engorgement... Not part of subscription


Company Profile | September 3, 2019

DiaMonTech's core technology employs photothermal detection, where mid‑infrared light beams specifically heat up blood glucose molecules noninvasively The molecular vibration from glucose leads to a deflection in the angle of the reflected light, which is measured using proprietary algorithms ... Not part of subscription

TouchPoint Solution

Company Snapshot | October 10, 2018

The company was founded by entrepreneur Vicki Mayo and neuropsychologist Amy Serin in December 2015. So far, the company has raised about $76,000 from Kickstarter and $250,000 from Indiegogo. The company makes a wearable device called TouchPoint that claims to reduce stress noninvasively by sending ... Not part of subscription